Conjugation of vascular endothelial growth factor to poly lactic-co-glycolic acid nanospheres enhances differentiation of embryonic stem cells to lymphatic endothelial cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Pluripotent stem cell-derived lymphatic endothelial cells (LECs) show great promise in their therapeutic application in the field of regenerative medicine related to lymphatic vessels. We tested the approach of forced differentiation of mouse embryonal stem cells into LECs using biodegradable poly lactic-co-glycolic acid (PLGA) nanospheres in conjugation with growth factors (vascular endothelial growth factors [VEGF-A and VEGF-C]).Methods: We evaluated the practical use of heparin-conjugated PLGA nanoparticles (molecular weight ~15,000) in conjugation with VEGF-A/C, embryoid body (EB) formation, and LEC differentiation using immunofluorescence staining followed by quantification and quantitative real-time polymerase chain reaction analysis.Results: We showed that formation and differentiation of EB with VEGF-A/C-conjugated PLGA nanospheres, compared to direct supplementation of VEGF-A/C to the EB differentiation media, greatly improved yield of LYVE1(+) LECs. Our analyses revealed that the enhanced potential of LEC differentiation using VEGF-A/C-conjugated PLGA nanospheres was mediated by elevation of expression of the genes that are important for lymphatic vessel formation.Conclusion: Together, we not only established an improved protocol for LEC differentiation using PLGA nanospheres but also provided a platform technology for the mechanistic study of LEC development in mammals.
Abstract
Objective: Pluripotent stem cell-derived lymphatic endothelial cells (LECs) show great promise in their therapeutic application in the field of regenerative medicine related to lymphatic vessels. We tested the approach of forced differentiation of mouse embryonal stem cells into LECs using biodegradable poly lactic-co-glycolic acid (PLGA) nanospheres in conjugation with growth factors (vascular endothelial growth factors [VEGF-A and VEGF-C]). Methods: We evaluated the practical use of heparin-conjugated PLGA nanoparticles (molecular weight ~15,000) in conjugation with VEGF-A/C, embryoid body (EB) formation, and LEC differentiation using immunofluorescence staining followed by quantification and quantitative real-time polymerase chain reaction analysis. Results: We showed that formation and differentiation of EB with VEGF-A/C-conjugated PLGA nanospheres, compared to direct supplementation of VEGF-A/C to the EB differentiation media, greatly improved yield of LYVE1(+) LECs. Our analyses revealed that the enhanced potential of LEC differentiation using VEGF-A/C-conjugated PLGA nanospheres was mediated by elevation of expression of the genes that are important for lymphatic vessel formation. Conclusion: Together, we not only established an improved protocol for LEC differentiation using PLGA nanospheres but also provided a platform technology for the mechanistic study of LEC development in mammals.
참고문헌 (27)
- Cueni LN, "The lymphatic system in health and disease", Lymphat Res Biol, 6, pp.109~122 (2008)[DOI]
- Baluk P, "Functionally specialized junctions between endothelial cells of lymphatic vessels", J Exp Med, 204, pp.2349~2362 (2007)[DOI]
- Yu P, "Lymphatic fate specification : an ERK-controlled transcriptional program", Microvasc Res, 96, pp.10~15 (2014)[DOI]
- Pichol-Thievend C, "Lymphatic vascular specification and its modulation during embryonic development", Microvasc Res, 96, pp.3~9 (2014)[DOI]
- Tammela T, "Lymphangiogenesis : molecular mechanisms and future promise", Cell, 140, pp.460~476 (2010)[DOI]
- Makinen T, "Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C", D receptor VEGFR-3, 2001, pp.20, 4762~4773
- Karkkainen MJ, "Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins", Nat Immunol, 5, pp.74~80 (2004)[DOI]
- Schulte-Merker S, "Lymphatic vascular morphogenesis in development, physiology, and disease", J Cell Biol, 193, pp.607~618 (2011)[DOI]
- Kunstfeld R, "Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia", Blood, 104, pp.1048~1057 (2004)[DOI]
- Lee SJ, "Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair", Sci Rep, 5, pp.11019~ (2015)[DOI]
- Kreuger J, "Early lymph vessel development from embryonic stem cells", Arterioscler Thromb Vasc Biol, 26, pp.1073~1078 (2006)[DOI]
- Kono T, "Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9stromal cells", Arterioscler Thromb Vasc Biol, 26, pp.2070~2076 (2006)[DOI]
- Alitalo K, "Lymphangiogenesis in development and human disease", Nature, 438, pp.946~953 (2005)[DOI]
- Lee MS, "Dual delivery of growth factors with coacervate-coated poly(lactic-co-glycolic acid)nanofiber improves neovascularization in a mouse skin flap model", Biomaterials, 124, pp.65~77 (2017)[DOI]
- La WG, "Heparin-conjugated poly(lactic-co-glycolic acid)nanospheres enhance large-wound healing by delivering growth factors in platelet-rich plasma", Artif Organs, 39, pp.388~394 (2015)[DOI]
- Jeon O, "Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide)nanospheres and fibrin gel", Biomaterials, 27, pp.1598~1607 (2006)[DOI]
- La WG, "The efficacy of bone morphogenetic protein-2 depends on its mode of delivery", Artif Organs, 34, pp.1150~1153 (2010)[DOI]
- Yang K, "Biodegradable nanotopography combined with neurotrophic signals enhances contact guidance and neuronal differentiation of human neural stem cells", Macromol Biosci, 15, pp.1348~1356 (2015)[DOI]
- Francois M, "Sox18 induces development of the lymphatic vasculature in mice", Nature, 456, pp.643~647 (2008)[DOI]
- Niessen K, "ALK1signaling regulates early postnatal lymphatic vessel development", Blood, 115, pp.1654~1661 (2010)[DOI]
- Moon EH, "Essential role for TMEM100 in vascular integrity but limited contributions to the pathogenesis of hereditary haemorrhagic telangiectasia", Cardiovasc Res, 105, pp.353~360 (2015)[DOI]
- Liersch R, "Induction of lymphatic endothelial cell differentiation in embryoid bodies", Blood, 107, pp.1214~1216 (2006)[DOI]
- Pan Y, "Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells", Microvasc Res, 94, pp.96~102 (2014)[DOI]
- Koltowska K, "Getting out and about : the emergence and morphogenesis of the vertebrate lymphatic vasculature", Development, 140, pp.1857~1870 (2013)[DOI]
- Norrmen C, "FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1", J Cell Biol, 185, pp.439~457 (2009)[DOI]
- Irrthum A, "Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia", Am J Hum Genet, 72, pp.1470~1478 (2003)[DOI]
- Mehrara BJ, "Lymphedema and obesity : is there a link", Plast Reconstr Surg, 134, pp.154~ (2014)[DOI]